BioConstBioConst 生物常量

研究・一般情報としての参考です。BioConst は内容を継続的に修正しますが、誤りを含む可能性があります。診断、投薬、検査、治療の判断は医師の指導に従ってください。

医学 Wiki

Alzheimer biomarkers

Amyloid, tau, neurodegeneration, imaging, CSF, and blood markers used to frame Alzheimer diagnosis, staging, and risk.

これは何か

Alzheimer biomarkers are biological measurements used to frame whether Alzheimer-related brain changes are present and how the disease may be staged.[1]

なぜ重要か

The 2024 criteria define Alzheimer disease biologically and incorporate core biomarkers, including imaging, CSF, and validated plasma approaches.[1]

どの判断に影響するか

  • Biomarkers can support diagnosis, staging, and risk framing, but they do not replace clinical interpretation or predict the fate of a single neuron.[1,2]

解釈上の注意

  • The criteria state that clinical biomarker use is presently intended for symptomatic individuals and not for cognitively unimpaired people outside research contexts.[1]

関連疾患